Illumina, Inc. (ILMN) — Stock Valuation & Research

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They…

ILMN key statistics

Price$237.37
Market cap$35.91B
SectorHealthcare
IndustryMedical - Diagnostics & Research
ExchangeNASDAQ
52-week range88-249.2
Beta1.47

Explore ILMN's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.